"Global Clinical Expert"

Medytox, a biopharmaceutical company led by CEO Hyunho Jung, announced on April 1 that it has appointed Tae-sang Lee as Executive Director overseeing the Clinical Development Division.


After earning a Ph.D. in pharmacy from Chung-Ang University, Executive Director Lee worked for more than 20 years at the global clinical team of Janssen Korea, where he managed the entire clinical development cycle and led regulatory approvals in the United States and Europe. Most recently, he served as Asia-Pacific leader, successfully spearheading numerous new drug development and overseas approval projects.

Tae-Sang Lee, Executive Director of Development Headquarters at Medytox. Medytox

Tae-Sang Lee, Executive Director of Development Headquarters at Medytox. Medytox

View original image

Medytox plans to further enhance its capabilities in establishing and managing global clinical strategies and accelerate its expansion into overseas markets.



Executive Director Lee stated, "Based on my global clinical experience, I will implement local clinical operation strategies and strengthen regulatory capabilities to help Medytox become a truly global company."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing